Navigation Links
Positive results from placebo-controlled phase IIa study in,patients suffering from house dust mite allergy

tients treated so far with QbG10 in the different studies, we can see the following
picture: QbG10 seems to be active as a monotherapy; however, combination with an allergen extract
at a standard dose appears to enhance the therapeutic effect. The highest efficacy was achieved
when QbG10 was combined with a dose of allergen extract usually applied in conventional
desensitization therapy, i.e. a 10-times higher dose than the one tested in this present study. In a
next clinical trial we will test higher doses of CYT003-QbG10 monotherapy and compare the safety
and efficacy profile directly with the most promising product formulations of CYT005-AllQbG10 in
order to select the best product candidate for late stage development.”

CYT003-QbG10 Conference Call and Webcast
Cytos Biotechnology will host a conference call and Q&A session today, Tuesday, May 15, 2007 at
10 am (CET) to discuss the study findings.
To access the conference call, please dial the following numbers:
Europe +41 91 610 56 00
U.S. +1 866 291 41 66
U.K. +44 207 107 06 11

The conference call will be held in English and will also be accessible by webcast on the internet.
You may follow the call live or have it replayed later on demand. To access the webcast and the
presentation, please follow the link provided on our homepage www.cytos.com. The presentation
slides will be available for download 30 minutes prior to the conference call.

Among other projects, Cytos Biotechnology will also discuss its allergy program at the company’s
upcoming R&D day on Wednesday, June 20, 2007 at 2 pm (CET) at the company’s premises in
Schlieren.

About the phase IIa study and the analysis
The multi-centre, randomized, double-blind and placebo-controlled phase IIa study included 40 male'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
2. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Protox Announces Positive Clinical Data from Prostate Cancer Study
5. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
6. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
7. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
8. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis
Post Your Comments:
(Date:9/1/2015)... and Delaware , United ... (ASX: IVX; "Company" or "Invion"), is pleased to announce that ... securities to an institutional investor in the United ... proceeds of approximately A$1.001 million ("Placement") by the issue of ... of $0.014 per share. The Company has ...
(Date:9/1/2015)... , Sept. 1, 2015 Nevro Corp. ... that is providing innovative evidence-based solutions for the treatment ... submitted its preliminary response to the Patent Trial and ... inter partes review (IPR), filed by a unit ... claims in U.S. Patent No. 8,359,102 (the ,102 patent). The ...
(Date:9/1/2015)... Calif. , Sept. 1, 2015 ... biopharmaceutical company focused on gastrointestinal and cardio-renal diseases, ... termination of the option and license agreement for ... 2015. There was no payment associated with termination ... February 2014, Ardelyx and Sanofi entered into an ...
Breaking Medicine Technology:Invion Announces Private Placement to US Institutional Investor 2Invion Announces Private Placement to US Institutional Investor 3Nevro Announces Submission of Preliminary Response to the Patent Trial and Appeals Board 2Ardelyx Regains NaP2b Program from Sanofi 2Ardelyx Regains NaP2b Program from Sanofi 3
... ... convenience to hospitals, reduce costs and lead to more efficient operating ... that once hospitals have converted to CPT, they will never convert ... using custom packs, but have also come to realise the true ...
... INDIANAPOLIS, Dec. 7 Roche Diagnostics announced today the opening ... as part of an initiative to make state-of-the-art training on ... the west and east coasts. Roche has an existing training ... open an additional facility in New Jersey in 2010. , ...
Cached Medicine Technology:Frost & Sullivan: Western European Markets Confirm Undisputed Convenience and Cost Benefit of Custom Procedure Trays 2Frost & Sullivan: Western European Markets Confirm Undisputed Convenience and Cost Benefit of Custom Procedure Trays 3Frost & Sullivan: Western European Markets Confirm Undisputed Convenience and Cost Benefit of Custom Procedure Trays 4Roche Diagnostics Opens State-of-the-Art Training Center in California 2
(Date:9/2/2015)... ... September 02, 2015 , ... “ G-Hold ” was featured on ... technology products available to consumers. Amanda Forstrom, a technology expert and special reporter for ... people to comfortably hold a tablet while reducing the likelihood of it dropping. , ...
(Date:9/2/2015)... ... September 02, 2015 , ... Please ... Aneurysm Awareness Month , which was established by the Foundation in 2007 with ... education, and helping fund more research remains our top priority,” commented Christine Buckley, ...
(Date:9/2/2015)... SC (PRWEB) , ... September 02, 2015 , ... ... announced today that he is now certified in “Systema”: a Russian martial art system ... aspects of life. , Systema , which dates back to the 10th ...
(Date:9/2/2015)... ... September 02, 2015 , ... Traveling to the Caribbean can be an ... flora and fauna. , Lifestyle Holidays Vacation Club knows that Puerto ... travelers experience that much better, Lifestyle Holidays Vacation Club has put together its list ...
(Date:9/1/2015)... ... September 01, 2015 , ... For many men, the first thing they notice when they go ... to wear a looser fitting shirt with a collar that doesn’t close against the skin, ... their collar and skin all day because it’s uncomfortable. Now men in suits will ...
Breaking Medicine News(10 mins):Health News:Comfortably Hold a Tablet with G-Hold Hands Free Tablet Holder 2Health News:September Celebrated as Brain Aneurysm Awareness Month 2Health News:Dr. Robert G. Schwartz Achieves Certification in Russian Martial Art “Systema” and Focuses on Integrating Techniques & Principles into Health Care Delivery 2Health News:Dr. Robert G. Schwartz Achieves Certification in Russian Martial Art “Systema” and Focuses on Integrating Techniques & Principles into Health Care Delivery 3Health News:Lifestyle Holidays Vacation Club Lists 3 Things to Consider When On a Puerto Plata Vacation 2Health News:Lifestyle Holidays Vacation Club Lists 3 Things to Consider When On a Puerto Plata Vacation 3Health News:Getting Rid of Double Chins: New FDA Approved Kybella Treatment Proving Very Popular Among Professional Men at Crutchfield Dermatology 2
... October 5, 2011 The Merck Childhood Asthma ... million in funding to implement the Community Healthcare ... partnership in five non-profit, Federally Qualified Health Centers. ... designed to demonstrate how asthma management tools proven ...
... (October 4, 2011)In a new study led by Fox ... have found that Gleason scores determined by pathologists at ... of recurrence than Gleason scores from referring institutions. ... Meeting of the American Society for Radiation Oncology on ...
... of Adelaide shows the parents of women with polycystic ovary syndrome ... PCOS is a hormonal disorder affecting about 10% of women ... endocrine disorders in women and a leading cause of infertility. ... to have any form of cardiovascular disease, and almost twice as ...
... TUESDAY, Oct. 4 (HealthDay News) -- Heart patients who have stenting ... they are released the same day as if they are sent ... "[Discharging patients the same day] wasn,t associated with any increased risk ... study appearing in the Oct. 5 issue of the Journal ...
... , WEDNESDAY, Oct. 5 (HealthDay News) -- Three hours of ... risk by 22 percent, a new study suggests. The ... 38 percent of that decreased risk was due to the ... high-density lipoprotein (HDL) cholesterol. The findings were published Oct. ...
... TUESDAY, Oct. 4 (HealthDay News) -- ,A common structural variation ... able to remember details of past events and to distinguish ... have imagined, scientists report. The study included 53 healthy ... Participants who lacked a fold at the front of the ...
Cached Medicine News:Health News:Childhood asthma non-profit invests millions in health centers to help children better manage asthma 2Health News:Childhood asthma non-profit invests millions in health centers to help children better manage asthma 3Health News:Fox Chase Gleason scores better predict prostate cancer's recurrence after radiation 2Health News:Fox Chase Gleason scores better predict prostate cancer's recurrence after radiation 3Health News:Overnight Stay May Not Be Necessary for Stenting: Study 2Health News:Overnight Stay May Not Be Necessary for Stenting: Study 3Health News:MRI Study Unfolds Clues to Memory 2
VISCO SHIELD Viscoelastic. Complete with 23g x 7/8" Thin Wall Cannula....
Interchangeable design allows you to select a single handpiece and change tips during the procedure. Universal connector. Disassembles for easy cleaning. Tips can rotate 360 degrees to re-orient port...
Interchangeable design allows you to select a single handpiece and change tips during the procedure. Universal connector. Disassembles for easy cleaning. Tips can rotate 360 degrees to re-orient port...
Interchangeable design allows you to select a single handpiece and change tips during the procedure. Universal connector. Disassembles for easy cleaning. Tips can rotate 360 degrees to re-orient port...
Medicine Products: